HTL-0027477

N/A

Report date: 2024/03/27 14:47:27
NMEFirst In Class

Base Information

Drug NameHTL-0027477
Drug Alias NameGSK-4381406GSK4381406HTL0027477HTL-0027477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 35 agonists
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNxera Pharma Co Ltd
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A